Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cipro XR for Acute Uncomplicated Lower UTI in Females
NCT00669994Phase 4Completed
- Sponsor
- Bayer
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofloxacin in urinary tract infection (UTI), sponsored by Bayer. Primary endpoint: Bacteriologic outcome in patients with UTI caused by S. saprophyticus. Started Jul 2003; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT00669994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669994.